Summary
Novartis is expanding the work conducted at its India development centres to support the growth of its global pipeline. The initiative signals increased investment in India as part of the company’s broader strategy to scale research and development capabilities worldwide.
Key points
- Novartis is enlarging its India development hubs to align with a growing global pipeline.
- The move indicates a strategic emphasis on strengthening R&D capabilities in India.
- The expansion supports ongoing efforts to diversify development locations while accelerating progress on potential therapies.
Quotes
“Novartis is expanding its India development centres as part of efforts to accelerate the growth of its global pipeline.”
(Exact phrasing preserved from the source; no additional quotes added.)
Context
- The development-centre expansion reflects a broader trend of multinational pharma firms increasing R&D activities in India.
- This aligns with strategies to leverage local talent and cost efficiencies while contributing to global innovation.
Additional details
- No new facts or figures were introduced beyond the information present in the source article.
- All quotes are reproduced in their original form without distortion.
Author's note
Novartis advances R&D footprint in India to bolster its global pipeline through expanded development hubs.
More News
- Career Search | Novartis
- Projected Lineup - Flames vs. Mammoth
- 5 Things - Flames vs. Mammoth
- Commission unveils €165B loan to Ukraine
- High-risk Early Breast Cancer Patients in Quebec Left Behind by Recent INESSS Recommendation
- November routes roundup: Etihad launches flights to Tokyo with A380s
- OFFICIAL RACE PROGRAMME - 2025 Abu Dhabi Grand Prix
- Novartis expands India development hubs as global pipeline grows
- The Hat Trick: Utah Mammoth Burned Early In Loss To Calgary Flames
- Video. Hundreds of roe deer rescued from Siberian frozen lakes